| 4SC AG |
| Abingworth Management Limited |
| Action Pharma A/S |
| Adamant Ventures |
| Aescap Venture |
| Affimed Therapeutics AG |
| AGF Private Equity |
| Akers Biosciences, Inc. |
| Algeta ASA |
| Alta Partners |
| AM-Pharma B.V. |
| Andhra Jyothy |
| Antisoma Research Ltd |
| Aravis Venture Associates AG |
| Ascent Therapeutics, Inc. |
| Atlas Venture |
| Avir Green Hills Biotechnology AG |
| Axentis Pharma AG |
| Axxam SpA |
| Baigo Capital GmbH |
| Bank Sarasin & Cie AG |
| Bay City Capital LLC |
| Bayhill Therapeutics, Inc. |
| BB Biotech Ventures |
| Biocrates Life Sciences GmbH |
| BioMedPartners |
| Bionest |
| BioScience Managers Limited |
| Biotec Pharmacon AS |
| biotech.com |
| Biotie Therapies Corp. |
| BioTOP Berlin-Brandenburg |
| Breslin AG |
| Bridgehead International |
| Bristol-Myers Squib |
| caprotec bioanalytics GmbH |
| Cellerix SA |
| Cerimon Pharmaceuticals, Inc. |
| Clavis Pharma ASA |
| Clinuvel |
| College Hill |
| Covagen AG |
| Credit Suisse |
| CureVac GmbH |
| Cylene Pharmaceuticals, Inc. |
| CytRx Corporation |
| Deloitte AG |
| Deutsche Bank AG |
| DeveloGen AG |
| DnB NOR Asset Management |
| Dow Jones |
| DyoDelta Biosciences |
| Eclosion |
| Edmond de Rothschild Investment Partners |
| Elm Biotech |
| ENDOCELLS |
| EnVivo Pharmaceuticals, Inc. |
| Equity Development Ltd. |
| ERYtech Pharma |
| ESBATech AG |
| Esteve Group |
| e-Therapeutics |
| ETV Capital |
| European Investment Fund |
| EVA - the Basel life sciences start-up agency |
| Evolva SA |
| Evotec AG |
| Excellentia Global Partners |
| F. Hoffmann-La Roche Ltd |
| Ferghana Partners |
| Forbion Capital Partners |
| Galantos Pharma GmbH |
| Gilde Investment Management B.V. |
| GiMV NV |
| GlaxoSmithKline |
| Global Life Science Ventures |
| Global Life Science Ventures AG |
| Grace Advisory |
| Haemostatix Ltd |
| HBM Partners AG |
| HealthCap |
| Helsinn Healthcare SA |
| Helvea SA |
| Hybrigenics SA |
| Immune Targeting Systems Ltd |
| Immunocore Ltd. |
| Inno Bio Ventures Sdn Bhd |
| InnovationsKapital |
| INVEST SECURITIES |
| Katan Associates |
| Kresta, Schnider & Partners AG |
| Kuros ApS |
| Le Temps |
| Lilly |
| LSP |
| Lumavita AG |
| Mellitech |
| Merck & Co. |
| Merck Serono International S.A. |
| Merck Serono SA |
| Microbiochips |
| MicroDiscovery GmbH |
| MPM Capital |
| N.M Rothschild & Sons Ltd |
| Nature Biotechnology |
| NGN Capital LLC |
| Nomura Code Securities |
| Novartis International AG |
| Novartis Vaccines & Diagnostics |
| Objective Capital |
| OctoPlus N.V. |
| Onelife Advisors SA |
| PharmaVentures Ltd. |
| PharmaWave Ltd |
| Phytopharm Plc |
| ProBioGen AG |
| Quest Management NV |
| Revotar Biopharmaceuticals AG |
| Roche Venture Fund |
| Sal. Oppenheim Jr. & Cie |
| Santaris Pharma A/S |
| Sensimed AG |
| Seventure Partners |
| Shire Pharmaceuticals Group plc |
| Siegfried Biologics |
| Sigma-Tau Pharma Ltd. |
| Silence Therapeutics plc |
| SIX Swiss Exchange AG |
| Staatz Business Development & Strategy |
| Synosia Therapeutics |
| TcLand Expression SA |
| Thiakis Limited |
| TiGenix NV |
| TPG Biotech/TPG Growth |
| UCB-Pharma AG |
| Uniobioscreen SA |
| Venture Valuation AG |
| Vesalius Biocapital |
| Warburg Pincus LLC |
| Werder Consulting |
| Wilex AG |
| WntResearch |
| Xeno Medical, Ltd |
| Xention Ltd. |
| Zürcher Kantonalbank |